3278158
Last Update Posted: 2019-03-22
Recruiting has ended
All Genders accepted | 30 Years-70 Years |
26 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2
This is a single-dose dose escalation trial in a randomised, single-blind, placebo-controlled group-comparison design to investigate the safety and tolerability of XEN-D0501 in subjects with diabetes mellitus type 2 where life style changes and treatment with metformin has failed to effectively reduce blood glucose concentrations.
Eligibility
Relevant conditions:
Diabetes Mellitus, Type 2
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov